Kelly Michael Aaron

CIK 00017696686 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001769668

Recent Transactions

50 trades

Award
Prime Medicine, Inc.$PRME
Stock Option (right to buy)
2026-06-05+75,000→ 75,000 total
Award
NEOGENOMICS INC$NEO
Restricted Stock Unit
2026-06-01+15,970→ 15,970 total
Exercise/Conversion
NEOGENOMICS INC$NEO
Common Stock
2026-06-01+23,077→ 67,086 total
Exercise/Conversion
NEOGENOMICS INC$NEO
Restricted Stock Unit
2026-06-01−23,077→ 0 total
Award
NEOGENOMICS INC$NEO
Stock Option (Right to Buy)
2026-06-01+11,069→ 11,069 total
Award
DMC Global Inc.$BOOM
Common Stock
2026-05-13+16,937→ 65,590 total
Disposition to Issuer
AMICUS THERAPEUTICS, INC.$FOLD
Stock Options (right to buy)
2026-04-27−74,872→ 0 total
Disposition to Issuer
AMICUS THERAPEUTICS, INC.$FOLD
Common Stock
2026-04-27$14.50/sh−72,468→ 0 total
Disposition to Issuer
AMICUS THERAPEUTICS, INC.$FOLD
Stock Options (right to buy)
2026-04-27−36,111→ 0 total
Disposition to Issuer
AMICUS THERAPEUTICS, INC.$FOLD
Stock Options (right to buy)
2026-04-27−45,423→ 0 total
Disposition to Issuer
AMICUS THERAPEUTICS, INC.$FOLD
Stock Options (right to buy)
2026-04-27−30,474→ 0 total
Disposition to Issuer
AMICUS THERAPEUTICS, INC.$FOLD
Stock Options (right to buy)
2026-04-27−42,467→ 0 total
Disposition to Issuer
Prime Medicine, Inc.$PRME
Stock Option (right to buy)
2025-08-01−39,062→ 0 total
Award
Prime Medicine, Inc.$PRME
Stock Option (right to buy)
2025-08-01+9,006→ 9,006 total
Disposition to Issuer
Prime Medicine, Inc.$PRME
Stock Option (right to buy)
2025-08-01−9,006→ 0 total
Award
Prime Medicine, Inc.$PRME
Stock Option (right to buy)
2025-08-01+13,510→ 13,510 total
Award
Prime Medicine, Inc.$PRME
Stock Option (right to buy)
2025-08-01+39,062→ 39,062 total
Award
Prime Medicine, Inc.$PRME
Stock Option (right to buy)
2025-08-01+45,000→ 45,000 total
Disposition to Issuer
Prime Medicine, Inc.$PRME
Stock Option (right to buy)
2025-08-01−13,510→ 0 total
Disposition to Issuer
Prime Medicine, Inc.$PRME
Stock Option (right to buy)
2025-08-01−45,000→ 0 total
Award
AMICUS THERAPEUTICS, INC.$FOLD
Common Stock
2025-06-05+20,414→ 72,468 total
Award
AMICUS THERAPEUTICS, INC.$FOLD
Stock Options (right to buy)
2025-06-05+74,872→ 74,872 total
Award
Prime Medicine, Inc.$PRME
Stock Option (right to buy)
2025-06-04+55,000→ 55,000 total
Award
NEOGENOMICS INC$NEO
Restricted Stock Unit
2025-06-01+23,077→ 23,077 total
Exercise/Conversion
NEOGENOMICS INC$NEO
Restricted Stock Unit
2025-06-01−12,254→ 0 total
Exercise/Conversion
NEOGENOMICS INC$NEO
Common Stock
2025-06-01+12,254→ 44,009 total
Award
NEOGENOMICS INC$NEO
Stock Option (Right to Buy)
2025-06-01+16,107→ 16,107 total
Purchase
NEOGENOMICS INC$NEO
Common Stock
2025-05-27$7.60/sh+5,000→ 5,000 total
Award
DMC Global Inc.$BOOM
Common Stock
2025-05-14+17,580→ 48,653 total
Award
DMC Global Inc.$BOOM
Common Stock
2025-02-26+5,518→ 31,073 total
Exercise/Conversion
NEOGENOMICS INC$NEO
Common Stock
2024-08-10+11,336→ 31,755 total
Exercise/Conversion
NEOGENOMICS INC$NEO
Restricted Stock Unit
2024-08-10−11,336→ 0 total
Award
Prime Medicine, Inc.$PRME
Stock Option (right to buy)
2024-06-12+45,000→ 45,000 total
Award
AMICUS THERAPEUTICS, INC.$FOLD
Common Stock
2024-06-06+11,847→ 52,054 total
Award
AMICUS THERAPEUTICS, INC.$FOLD
Stock Options (right to buy)
2024-06-06+42,467→ 42,467 total
Award
NEOGENOMICS INC$NEO
Restricted Stock Unit
2024-06-01+12,254→ 12,254 total
Award
NEOGENOMICS INC$NEO
Stock Option (Right to Buy)
2024-06-01+8,672→ 8,672 total
Award
DMC Global Inc.$BOOM
Common Stock
2024-05-15+9,520→ 25,555 total
Award
NEOGENOMICS INC$NEO
Restricted Stock Unit
2023-08-10+11,336→ 11,336 total
Award
NEOGENOMICS INC$NEO
Stock Option (Right to Buy)
2023-08-10+8,353→ 8,353 total
Award
Prime Medicine, Inc.$PRME
Stock Option (right to buy)
2023-06-14+39,062→ 39,062 total
Award
AMICUS THERAPEUTICS, INC.$FOLD
Stock Options (right to buy)
2023-06-08+30,474→ 30,474 total
Award
AMICUS THERAPEUTICS, INC.$FOLD
Common Stock
2023-06-08+8,584→ 40,207 total
Award
DMC Global Inc.$BOOM
Common Stock
2023-05-10+7,086→ 16,035 total
Award
Prime Medicine, Inc.$PRME
Stock Option (right to buy)
2022-10-19+9,006→ 9,006 total
Award
HOOKIPA Pharma Inc.$HOOK
Stock Option (Right to Buy)
2022-06-30+20,000→ 20,000 total
Award
NEOGENOMICS INC$NEO
Stock Option (Right to Buy)
2022-06-10+13,882→ 13,882 total
Award
NEOGENOMICS INC$NEO
Common Stock
2022-06-10+15,556→ 20,419 total
Award
AMICUS THERAPEUTICS, INC.$FOLD
Stock Options (right to buy)
2022-06-09+45,423→ 45,423 total
Award
AMICUS THERAPEUTICS, INC.$FOLD
Common Stock
2022-06-09+12,671→ 31,623 total

Companies

Recent Filings

Address

C/O PRIME MEDICINE, INC. 60 FIRST STREET

CAMBRIDGE, MA, 02141

View on SEC.gov